Stephanopoulos:Production of biochemicals in E. coli: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
A major focus of the Stephanopoulos lab is development of E. coli-based biocatalysts. Target products include antioxidant [[carotenoid]]s such as [[lycopene]] as well as amino acids such as [[tyrosine]], which we are producing with an eye toward [[commodity-polymer]] applications. | A major focus of the Stephanopoulos lab is development of ''E. coli''-based biocatalysts. Target products include antioxidant [[carotenoid]]s such as [[lycopene]] as well as amino acids such as [[tyrosine]], which we are producing with an eye toward [[commodity-polymer]] applications. | ||
To develop strains, we employ rational, model-based approaches as well as [[Stephanopoulos Lab:Inverse Metabolic Engineering | combinatoric ones]], and have been enthusiastic adopters of the whole-cell stoichiometric models developed by Bernard Palsson and Costas Maranas. | To develop strains, we employ rational, model-based approaches as well as [[Stephanopoulos Lab:Inverse Metabolic Engineering | combinatoric ones]], and have been enthusiastic adopters of the whole-cell stoichiometric models developed by Bernard Palsson and Costas Maranas. | ||
Revision as of 16:10, 12 July 2006
A major focus of the Stephanopoulos lab is development of E. coli-based biocatalysts. Target products include antioxidant carotenoids such as lycopene as well as amino acids such as tyrosine, which we are producing with an eye toward commodity-polymer applications.
To develop strains, we employ rational, model-based approaches as well as combinatoric ones, and have been enthusiastic adopters of the whole-cell stoichiometric models developed by Bernard Palsson and Costas Maranas.
